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Four renal isografls have been performed and all have had 
satisfactory function for 7'h to 17;3 years without prophylactic 
or therapeutic Immunosuppression. Three of these patients 
originally had glomerulonephritis, and in one there was 
histologic evidence of recurrent disease, 7"2 years aner trans-
plantation, without proteinura and without change in renal 
function. Although this experience is small, it suggests that 
prophylactic immunosuppression is not appropriate for 
recipients of renal isografls. 
BETWEEN 1954 AND 1965 THE BOSTON experience 
with 22 renal transplants from presumed identical 
twins included 17 recipients with probable subacute or 
chronic glomerulonephritis. 4.8-10.13 Eleven of these 17 
patients developed in their isotransplanted kidneys 
glomerular disease which was thought to' represent 
recurrent glomerulonephritis. It was suggested by the 
authors that prophylactic or therapeutic immuno-
suppression is beneficial in preventing or treating re-
current glomerulonephritis." 
In Denver, no immunosuppression has been given to 
the four recipients of identical twin kidney transplants 
who are the subject of this report. 
Clinical Material and Results 
Between January, 1962 and Feburary, 1972, four 
patients received kidney transplants in Denver from 
presumed identical twin donors. None have received 
prophylactic or therapeutic immunosuppressive agents 
of any kind and none have received prophylactic 
antibiotics since transplantation. 
Three of the four patients had chronic glomerulo-
nephritis originally and one had chronic pyelonephritis 
(Table 1). These diagnoses were confirmed histologically 
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in the three patients whose own kidneys (and spleens) 
were removed at the time of transplantation. The first 
recipient still has his original kidneys and he has de. 
clined to have his transplanted kidney biopsied. 
All four patients have good kidney function, witb 
recent (1978/1979) serum creatinines less than 1.5 mg/dl 
and creatinine clearances of at least 60 m1!min and no 
proteinuria (Table I). The renal function in all patients 
has been stable essentially since the time of trans-
plantation. 
Renal Biopsy Results 
In 1978 three patients had open biopsies of their 
transplanted kidneys. One of the biopsied patients (HO) 
originally had chronic pyelonephritis. Her biopsy, done 
11 years after transplantation, revealed a normal kid-
ney. Biopsies in two patients who originally had chronic 
glomerulonephritis revealed a normal transplant in one 
(FR) and recurrent glomerulonephritis in the other (JB). 
The patient with recurrent disease received her trans-
plant in 1972, six years before the biopsy was done: 
the changes in the biopsy specimen (Fig. I) resembled 
the type 1 mesangiocapillary glomerulonephritis found 
in her own kidneys at the time of nephrectomy ill 
1972. Light microscopy showed some generalized in-
crease in the number of mesangial cells, slight segmental 
thickening of the glomerular capillary walls and aD 
increase in the amount of mesangial matrix. Immuno-
peroxidase revealed generalized and diffuse granular 
deposits of IgG, IgM, IgA, C3, Clq and C4 in the 
mesangium and in the capillary walls. Ultrastructurally, 
the capillary basement membranes were ..... g~ .. J ...... -. 
thickened by large subendothelial collections of 
granular electron dense material and by I';'r f'.I1,...f" .. 
mesangial cell interposition. The mesangium also 
tained deposits of electron dense material. .... J .. I-K~K 
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TABLE 1. Clinical Characteristics of Four Patients with Renall.fograJts 
Bilateral Current 
Date of Original Nephrectomy, Creatinine Current 1978 Renal 
Patient Transplant Disease Splenectomy Clearance Proteinuria Biopsy 
JW Jan. 1962 CGN No 
FR July 1963 CGN Yes 
HO April 1966 Pyelo. Yes 
JB Feb. 1972 CGN Yes 
• Patient declined. 
e1ectronmicroscopy confirme"lt that the immunoglobulins 
and complement were located in the subendothelial 
and mesangial deposits. Analysis of this patient's 
serum obtained in August 1978 revealed a low total 
hemolytic complement (48%; normal range 60-140) but 
normal C3, Clq and C4, and no nephritic factor (C3 
NeF). The Clq binding assay16 showed that immune 
complexes consisting ofIgG, IgM and C3 were present. 
DNA binding was normal. There is no clinical evidence 
of infection in this patient. Urine culture for cytomegalo-
virus in August 1978 was negative. This patient has 
had no detectable proteinuria. 
85 mllmin 0 None· 
110 mUmin 0 Normal 
60 mUmin 0 Normal 
60 mllmin 0 Recurrent 
glomerulo-
nephritis 
Discussion 
The first successful renal isograft was performed in 
Boston in 1954; 28 additional cases had been done at the 
Peter Bent-Brigham Hospital by March, 1976. 10 Seven-
teen of the original 22 renal isograft patients had 
glomerulonephritis, and recurrent disease was diag-
nosed in 11 ofthese 17 patients; seven of the 11 patients 
with recurrent disease died 0.5 to 99 months after trans-
plantation, and the recurrence was considered a major 
co-ntributing cause in six of the seven deaths. 4 Three of 
the 17 patients with glomerulonephritis received pro-
~o: 1. Electron micrograph of part of a glomerular capillary loop from patient JB's renal isograft. There are two large subendothelial 
Iu"'a Sits (dep) on the capillary basement membrane and there is mesangial cell interposition (mes) in the capillary wall. cap = capillary 
·• ... n (x 13,940). 
._-_ .. _ .. _._-,._----,---
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phylactic immunosuppression beginning at or near the 
time of transplantation: one developed recurrent dis-
ease two days after transplantation and died two weeks 
after transplantation, and two have had no recurrence. 
Six patients received immunosuppressive treatment 
following discovery of recurrent glomerulonephritis: 
four died after 4-27 months of immunosuppressive 
therapy without improvement in renal function, and 
two patients survived without significant improvement 
in renal function.4.8 
In Japan there were three cases of recurrent glomerulo-
nephritis in the first 5 isografts done there, and Tagaki 
recommended the use of small doses of prophylactic 
azathioprine to try to prevent recurrence;5 however 
there is no clear evidence to suggest that this approach 
would in fact lower the recurrence rate. 
The histologic differentiation of recurrent disease 
from rejection can be extremely difficult in renal allo-
grafts:l·6•12 but in renal isografts it is assumed that rejec-
tion is not operative and that any histopathologic 
changes are due to mechanisms other than rejection. 
In our patient with recurrent mesangiocapillary glom-
erulonephritis without proteinuria, the clinical signifi-
cance of the immunopathologic findings is uncertain. 
Histologic recurrence of type 1 mesangiocapillary glo-
merulonephritis is known to be consistent during a long 
period with good transplant function, particularly when 
there is no cl inical or urinary abnormality. \I 
The possibility that host nephrectomy may reduce 
the frequency of recurrent glomerulonephritis is difficult 
to assess in our patients. One of our three patients 
with chronic glomerulonephritis has not had his own 
kidneys removed and has no clinical evidence oLrecur- ~ 
rent disease 17¥.3 years after transplantation (no biopsy 
done); on the other hand, our one patient with recur-
rent disease did have her own kidneys removed at the 
time of transplantation. In the Boston experience the 
time of removal of the patient's own kidneys did not 
influence recurrence. 8 
The possible benefit of prophylactic antibiotics, to 
prevent streptococcal infection and nephritis, is also 
difficult to assess in our patients. None of our four 
patients were treated with prophylactic antistreptococ-
cal agents. Some of the Boston patients received pro-
phylactic antibiotics,9 but the role of streptococcal 
infection in the genesis of recurrence in their patients 
was not established. 4 
The likelihood that the four Denver patients would 
have had better clinical courses with than without pro-
phylactic immunosuppression seems small. All three of 
the patients who originally had chronic glomerulo-
nephritis have had good graft function for 7Y.! to 1T~ 
years since transplantation, with current creatinine 
clearances of 60-85 ml per minute. Furthermore, it is 
not unlikely that so many years of immunosuppression 
would have been associated with complications of 
immunosuppression such as Cushing's syndrome, aseptic 
necrosis, or cataracts. 14 
The poor response of the six Boston patients to 
immunosuppression started after the onset of recurrent 
glomerulonephritis,4 and the uncertain value of immuno-
suppression of glomerulonephritis in nontransplanted 
kidneys I.2.7.'5 have disuaded us from subjecting our pa. 
tient who has recurrent disease without proteinuria to 
the risk of immunosuppression. 
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